Previously, in clinical glioma specimens, we found decreased expression of BMPR-IB mRNA and protein in malignant glioma tissues compared to the levels in normal brain tissues and benign glioma tissues, whereas the expression of other molecules in the signaling pathway of BMPs/Smad1/5/8 remained consistent. The gene discussed is CLN5; the disease is central nervous system cancer.